The biomechanics held up and the market never rewarded them. What survives, who still sells it, and why nobody has launched a new one in fifteen years.
There is a simple test for whether a spine category is finished, and it is not the sales line. It is whether anyone is still spending money on it. New platforms, new clearances, new trials. By that test, translational cervical plating stopped being a category somewhere around 2016, even though you can still buy one this afternoon from several manufacturers.
The premise was never weak. An anterior cervical construct is a race between fusion and hardware fatigue, and if the graft settles while the plate stays rigid, the plate ends up carrying load that the bone should be carrying. Dynamic designs answered that by letting the construct shorten in a controlled way, keeping compressive load on the graft. The literature sorts them into rotational plates, where screws toggle in fixed holes; translational plates, where the screw slides axially in a slot or the plate itself shortens through a ratchet or telescoping segments; and hybrids combining both behaviors.
Cadaveric work backed the theory cleanly. In a JBJS study of 21 C2–T1 specimens with a C5 corpectomy, all three plate types shared load equally at time zero, but after 10% simulated graft subsidence the static plate stopped sharing load and stopped limiting motion, while both dynamic designs held their function.
The clinical literature never delivered the follow-through, and the comparative evidence is thinner than the debate around it suggests. A blinded randomized trial pitting a static Synthes CSLP against Medtronic’s Atlantis Vision (angular dynamization) and Premier (translational dynamization) in two-level fusions found no advantage for either dynamic design on fusion rate, time to fusion, subsidence, complications or adjacent-level reoperation, and observed that static constructs subsided at broadly similar levels anyway. That trial randomized 36 patients across three arms, which is 12 per arm, so it settles nothing on its own. The larger dataset is a systematic review of 52 studies and 3,053 patients, which found fusion of 96.1% with fully constrained plates against 95.29% with semiconstrained, and no difference in complications. Note the categories, though: semiconstrained pools rotational and translational designs together, so it is a proxy for the question and not an answer to it.
The counterargument deserves its space. A separate systematic review covering 172 dynamic and 143 static patients reported comparable clinical outcomes overall, and within it two randomized studies concentrated hardware complications entirely in the static arm, four failures against none. A retrospective series with five-year follow-up found equivalent fusion but better maintenance of disc height with static plates in single-level cases. The fair reading is that dynamization traded construct height for implant durability, in a procedure where both usually turn out acceptable.
What killed the category?
Not that debate. It was the collapse of the addressable procedure underneath it, as zero-profile and integrated stand-alone interbodies absorbed the one- and two-level ACDF volume that plates used to own, and arthroplasty took another slice of the same pool. What remains for anterior plating is multilevel disease, corpectomy, poor bone, revision and surgeon habit. Multilevel is exactly where dynamization had its strongest theoretical case and also where uneven settling across three or four levels makes its behavior least predictable, and where posterior instrumentation is increasingly the competing answer instead of a different plate.
The adjacent-level ossification argument went the same way. Dynamic plates were partly sold on reducing ALOD, but a construct designed to settle brings the plate edges closer to the neighboring discs, which is the known risk geometry. The clearest statement of the problem came from the manufacturer that had built the category. In its own surgical technique for Atlantis Translational, Medtronic wrote that the first translational designs brought significant drawbacks including encroachment on adjacent level discs and bulky high-profile mechanisms that limited visualization, and that the bidirectional loading and off-loading of the grafts was concerning. Industry solved it by geometry instead. Medtronic’s ZEVO was built around short plate options and hyper-angulated screws precisely to keep the plate as far from the adjacent disc as possible, and MiRus took its CYGNUS plate through 510(k) in October 2023 on a molybdenum-rhenium alloy that allows an unusually thin, narrow profile. Both are innovations in footprint and material. Neither is an innovation in kinematics.
What are the competitors?
So what is actually still on the shelf. Globus Medical lists ASSURE-T in its own catalog as a translational plate, sitting beside ASSURE, ASSURE-X, the ex-NuVasive ACP, RESONATE and the COALITION AGX plate. Aesculap still carries ABC2 with dynamic load sharing as its stated pitch, the screw sliding in the plate, although we have confirmed this through catalog listings and not directly with the manufacturer. DePuy Synthes keeps the older translational Vectra-T in circulation, with regional marketing status unconfirmed. Medtronic’s Premier, cleared in 1999 under K992110 and the translational arm of the randomized trial above, still shows plate sizes in commercial distribution, with the FSP family ended in October 2018; in February 2019 Medtronic ran Premier through a single clearance shared with Atlantis, Divergence, Venture, Zephir and ZEVO. Pyrenees Translational left Stryker in April 2025, when Viscogliosi Brothers completed the carve-out and created VB Spine, and remains listed in commercial distribution under the new owner.
The translational plates that can actually be identified today:
- ABC2 E-Plate
- ASSURE™-T translational plate
- Atlantis Translational
- AntCer II
- DynaTran®
- KINETIC-SL
- Mambo® modular cervical plate system
- Pyrenees Translational
- PREMIER® Anterior Cervical Plate
- Rhausler Anterior Cervical Vertebrae Plate System
- UNIFY® anterior cervical plate system
- Vectra-T
Twelve, with one caveat and three exclusions. The Rhausler Dynamic plate qualifies on its own surgical technique, which describes translation and rotation at the plate-screw interface and instructs the surgeon to cover only a third to a half of the vertebral body to leave room for expected settling. That mechanism appears nowhere in the company’s commercial material and only in a technique guide last revised in 2011, which tells you most of what you need to know about how long nobody has been selling this. Strictly it is a hybrid, since the screw rotates as well as translates. The Nexus Active plate, by contrast, does not belong here at all: superelastic nitinol applies compression actively, which is a different principle from controlled passive settling. And the two systems most often mistaken for the category are not in it either: SKYLINE, offered in variable, constrained or hybrid screw configuration, and Trinica and Trinica Select, now inside Highridge Medical after the Zimmer Biomet divestiture, are rotational designs, where the screw toggles in a fixed hole and nothing shortens.
That list carries the real finding. Almost nobody sells a translational plate as a product any more; they sell a plate platform on which dynamization is one screw option among several, chosen level by level at the table. The category dissolved into a feature, and features do not get their own tenders. Read the roster by owner and the same conclusion arrives from the corporate side: ASSURE-T inside Globus alongside the ex-NuVasive ACP, Vectra-T inside a DePuy Synthes that Johnson & Johnson has been reported to be exploring a sale of, Pyrenees inside a business Stryker chose to exit. Every recognizable translational plate now sits in a company that was sold, carved out or put on the block.
How big is the market?
Market sizing on this segment should be treated with open skepticism. Published estimates for anterior cervical plating range from roughly $960 million in 2024 to $1.8 billion in 2025, with forecast CAGRs from 4.1% to 9.4% depending on whose report you open, a spread wide enough to tell you the segment is being modeled and not measured. The most useful signal in any of them comes from iData Research, whose global cervical fixation work points toward roughly $2.6 billion by 2031 at 4.1%, and which frames technological improvement in this space as something that slows the decline in ASPs instead of reversing it. That is the honest description of a commoditized category. At least one syndicated report still projects the dynamic plating segment as a growth story, a claim that appears in template segmentation and nowhere in the launch record.
Is the category dead?
Not as inventory, and not in the operating room, where dynamization survives as a screw option inside mostly static systems and as a named SKU in a small number of catalogs. It is dead as a purchasing decision and as a marketing story. The clearance record shows no new translational platform brought to market in fifteen years, and no meaningful comparative trial published since 2016, which describes a business that is being harvested and not one that is being run.
###
Legal Disclaimer:
Content published on SPINEMarketGroup (thespinemarketgroup.com) is provided for informational purposes only and on an “as is” basis, without warranties of any kind. We do not guarantee the accuracy, completeness, legality, or reliability of any information, images, videos, links, or third-party materials featured on the site. Any views or claims expressed in contributed content or press releases belong to their respective authors or sources. For copyright concerns, factual corrections, or content-related complaints, please contact us directly for review.